Mr. Jagodzinski serves as Controller and Treasurer. He started his career in Accounting / Finance with Vascular Solutions in 2013 as a Cost Accountant and held roles with increasing responsibility prior to and after its acquisition by Teleflex, Inc., most recently serving as the Sr. Finance Director for its Interventional business unit.  During his 10 years with VSI and Teleflex, Mr. Jagodzinski supported several M&A transactions and their subsequent integrations, held responsibilities for both manufacturing and commercial operations, and was the Finance lead for several enterprise-level new product development initiatives. Mr. Jagodzinski has a B.S. in Accounting from the University of St. Thomas (MN) and holds an active CPA certificate.

Ms. Powers has served as President and Chief Executive Officer of Reprise since co-founding the company in May 2019. From 2006 through February 2018, Ms. Powers held a succession of positions of increasing responsibility at Vascular Solutions, Inc., starting as Associate Product Manager in 2006 and rising to Senior Vice President of Marketing at the time of the company’s acquisition by Teleflex Incorporated in 2017. Following that acquisition, Ms. Powers continued in management at Teleflex in the role of Senior Director of Clinical & Medical Affairs. From March 2018 to February 2019, Ms. Powers served on the management team of the medical device company CHF Solutions, Inc., first as its Vice President of Marketing and most recently as its Senior Vice President of Commercial Operations. Prior to joining Vascular Solutions, Ms. Powers was employed by St. Mary’s Hospital in Madison, Wisconsin from 2002 to 2006, most recently as a Registered Nurse in the Interventional Cardiac Catheterization Lab.

Dr. Isenburg has served as Vice President of Research & Development for Reprise since June 2019. From 2010 through May 2019, Dr. Isenburg was employed at Vascular Solutions, Inc. first as a Senior Biological Development Scientist and, following the company’s acquisition by Teleflex Incorporated, as Director of Scientific Affairs. Previous to Vascular Solutions, from 2007 to 2010, Dr. Isenburg served as a Senior Research Scientist at Vatrix Medical, a start-up medical device company based on his own patented research, with a focus on the diagnosis and treatment of aneurysms. Dr. Isenburg holds a Ph.D. in Bioengineering from Clemson University and a B.S. in Chemical Engineering from Rose-Hulman Institute of Technology.

Ms. Kotila has served as Vice President of Human Resources at Reprise since May 2019. Ms. Kotila began her career in Human Resources at Vascular Solutions, Inc. 2000, holding positions of increasing responsibility starting as Human Resources Associate and rising to Director of Human Resources at the time of the company’s acquisition by Teleflex Incorporated in 2017.   From March 2017 to May 2019, Ms. Kotila joined Sleep Number Corporation as their Sr. Benefits Analyst. Ms. Kotila holds a PHR certification from the HR Certification Institute.

Mr. Krueger has served as the Vice President of Manufacturing at Reprise Biomedical since October 2022.  Mr. Krueger brings 20 years of medical device manufacturing and operations experience, with additional experience in telecommunications.  Prior to joining Reprise, Mr. Krueger served as the Director of Manufacturing Engineering at Vascular Solutions, Inc., and following the company’s acquisition by Teleflex Incorporated, expanded his areas of management to include custom equipment design, packaging engineering, and manufacturing technology functions with responsibilities for new product development activities, due diligence for technology acquisitions, and manufacturing site transfer activities.  Prior to Vascular Solutions, from 2003 – 2009, Mr. Krueger was employed by Boston Scientific in various process development engineering roles.  Mr. Krueger holds a degree from the University of Minnesota in Manufacturing and Operations Management.

Mr. Jagodzinski serves as Controller and Treasurer. He started his career in Accounting / Finance with Vascular Solutions in 2013 as a Cost Accountant and held roles with increasing responsibility prior to and after its acquisition by Teleflex, Inc., most recently serving as the Sr. Finance Director for its Interventional business unit.  During his 10 years with VSI and Teleflex, Mr. Jagodzinski supported several M&A transactions and their subsequent integrations, held responsibilities for both manufacturing and commercial operations, and was the Finance lead for several enterprise-level new product development initiatives. Mr. Jagodzinski has a B.S. in Accounting from the University of St. Thomas (MN) and holds an active CPA certificate.

Mr. Smock serves as General Counsel and Chief Compliance Officer at Reprise.  He has responsibility for all legal, compliance, and intellectual property matters.  Before joining Reprise, from 2013 to 2023, Mr. Smock served as Intellectual Property Counsel at Vascular Solutions, Inc., and later Teleflex Incorporated, where he advised on intellectual property and transactional matters, including patent portfolio strategy, development and enforcement, due diligence and counseling in connection with acquisitions and divestitures, and licensing and other technology transactions.  Mr. Smock began his legal career at a Minneapolis-based intellectual property law firm, where, from 2005 to 2013, he represented medical device, industrial, and other growth companies and investors in the protection of emerging technologies.  Mr. Smock earned his J.D. from the University of Minnesota School of Law and his B.S. from North Dakota State University. He is a registered U.S. patent attorney.

Mr. Duncan has been Vice President of Quality at Reprise Biomedical since October 2024, bringing over 25 years of experience in quality management across the medical device, biologics, and pharmaceutical sectors.  Before joining Reprise Biomedical, Mr. Duncan was Vice President of Quality at Resolve Surgical Technologies (formerly RTI Surgical) from January 2023 to May 2024, following his role as Director of Quality from September 2020 to December 2022. He also served as Global Quality Director at Smiths Medical from 2017 to September 2020.  From 2005 to 2017, Mr. Duncan held progressive leadership roles in quality at Vascular Solutions, culminating as Senior Director of Quality at the time of its acquisition by Teleflex Incorporated in 2017.  Mr. Duncan holds a Bachelor of Science in Chemical Engineering from Michigan Technological University and is currently pursuing an MBA with a focus on Management and Leadership at Saint Cloud State University.